Lipsore

Aciclovir, the active ingredient in Lipsore, is an antiviral presented as a topical preparation for external use. It is used to treat localized herpes virus infections such as cold sores, genital herpes lesions, and shingles in patients requiring topical therapy.

GNH USA supplies Lipsore as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and offers reliable global distribution. GNH USA maintains GMP‑certified manufacturing facilities and offers regulatory support for importers.

Lipsore is an antiviral agent applied to the skin for herpes‑related conditions. - Herpes labialis (cold sores): Reduces lesion duration and promotes healing of oral lip lesions. - Genital herpes (topical treatment): Decreases viral replication in external genital lesions, aiding symptom relief. - Herpes zoster (localized lesions): Limits viral spread in skin lesions, supporting faster resolution.

Topical aciclovir may cause local reactions.

Common Side Effects: - Burning sensation at the application site. - Itching or mild irritation. - Redness or erythema of the skin. - Dryness or peeling of treated area. - Mild pain or tenderness.

Serious or Rare Side Effects: - Allergic contact dermatitis with swelling or rash. - Severe skin irritation or ulceration. - Erythema multiforme or Stevens‑Johnson syndrome (very rare). - Systemic hypersensitivity reactions. - Persistent ulceration despite discontinuation.

Before using Lipsore, consider the following safety measures. - Confirm viral etiology: ensure lesions are caused by herpes viruses before application. - Avoid mucous membranes: limit use to external skin lesions only. - Do not apply to extensive, deep or infected wounds. - Discontinue if severe irritation, swelling, or allergic reaction occurs. - Store at room temperature: keep in the original container, protect from moisture and light.

Topical aciclovir has limited systemic interactions, but caution is advised.

Major Interactions (Avoid): - Concurrent use of other topical antivirals: may increase local toxicity. - Systemic antiviral therapy (e.g., oral aciclovir): risk of cumulative exposure.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce antiviral efficacy. - Topical immunosuppressants: may increase risk of secondary infection. - Alcohol‑based skin cleansers: may enhance irritation at the application site.